經歷了2009年的低迷之后，2010年，全球農藥市場已經出現了恢復增長的勢頭。2010年全球農藥銷售額達407億美元，與2009年基本持平。其中，世界六大農化巨頭拜耳、先正達、陶氏、巴斯夫、孟山都和杜邦公司就占據了全球農藥市場70%以上的份額。
而(er)上(shang)月中國(guo)農(nong)藥工(gong)業(ye)協會組織評選發布的2010年中國(guo)農(nong)藥銷(xiao)(xiao)(xiao)售(shou)(shou)百強企業(ye)榜(bang)單顯示，浙江新安化工(gong)集(ji)團股份(fen)有限(xian)公(gong)(gong)司以18.73億元的農(nong)藥銷(xiao)(xiao)(xiao)售(shou)(shou)額(e)榮登(deng)榜(bang)首。站在百強起跑線的是(shi)陜西上(shang)格之路生物科(ke)學(xue)有限(xian)公(gong)(gong)司，農(nong)藥銷(xiao)(xiao)(xiao)售(shou)(shou)額(e)1.7億元。經初步(bu)計算(suan)兩(liang)相對比，國(guo)內農(nong)藥百強企業(ye)總銷(xiao)(xiao)(xiao)售(shou)(shou)收入496.97億元，約合77.65億美元，而(er)2010年農(nong)藥銷(xiao)(xiao)(xiao)售(shou)(shou)世界排名第(di)一的先正(zheng)達集(ji)團業(ye)績(ji)就高達88.41億美元，不(bu)禁(jin)讓人驚嘆，中國(guo)百強企業(ye)的年銷(xiao)(xiao)(xiao)售(shou)(shou)收入全加起來還不(bu)及(ji)一家國(guo)際大公(gong)(gong)司的銷(xiao)(xiao)(xiao)售(shou)(shou)收入!
如今(jin)，2011年(nian)(nian)(nian)末將至，各大農(nong)(nong)藥(yao)(yao)公(gong)(gong)(gong)(gong)司(si)(si)近期紛紛發布了今(jin)年(nian)(nian)(nian)農(nong)(nong)藥(yao)(yao)半年(nian)(nian)(nian)度及季度銷(xiao)售(shou)(shou)業(ye)(ye)績。先正(zheng)達公(gong)(gong)(gong)(gong)布的(de)(de)(de)上(shang)半年(nian)(nian)(nian)業(ye)(ye)績報(bao)告(gao)顯示(shi)，銷(xiao)售(shou)(shou)額(e)(e)77億美(mei)元，增(zeng)長(chang)(chang)(chang)14%；凈利(li)潤14億美(mei)元，增(zeng)長(chang)(chang)(chang)14%。陶氏化學健康和(he)農(nong)(nong)業(ye)(ye)科技業(ye)(ye)務(wu)板塊上(shang)半年(nian)(nian)(nian)的(de)(de)(de)銷(xiao)售(shou)(shou)額(e)(e)超過(guo)30億美(mei)元，再創歷史(shi)新(xin)(xin)高。巴斯夫上(shang)半年(nian)(nian)(nian)業(ye)(ye)務(wu)增(zeng)長(chang)(chang)(chang)同(tong)樣也強(qiang)勁，銷(xiao)售(shou)(shou)額(e)(e)同(tong)比增(zeng)長(chang)(chang)(chang)19.4%。而根據國內農(nong)(nong)藥(yao)(yao)18家上(shang)市公(gong)(gong)(gong)(gong)司(si)(si)的(de)(de)(de)半年(nian)(nian)(nian)報(bao)顯示(shi)，6家企(qi)業(ye)(ye)業(ye)(ye)績虧(kui)損，5家企(qi)業(ye)(ye)利(li)潤同(tong)比下滑(hua)。位列百強(qiang)企(qi)業(ye)(ye)前十五位的(de)(de)(de)浙(zhe)江新(xin)(xin)安化工(gong)公(gong)(gong)(gong)(gong)司(si)(si)、南通江山農(nong)(nong)藥(yao)(yao)化工(gong)公(gong)(gong)(gong)(gong)司(si)(si)和(he)安徽(hui)華星化工(gong)公(gong)(gong)(gong)(gong)司(si)(si)等(deng)都(dou)在虧(kui)損之(zhi)(zhi)列。這(zhe)(zhe)業(ye)(ye)績的(de)(de)(de)天(tian)壤之(zhi)(zhi)別是(shi)(shi)對中(zhong)國農(nong)(nong)藥(yao)(yao)企(qi)業(ye)(ye)的(de)(de)(de)嚴厲拷問：如何縮(suo)短中(zhong)國農(nong)(nong)藥(yao)(yao)企(qi)業(ye)(ye)與農(nong)(nong)化巨頭(tou)之(zhi)(zhi)間的(de)(de)(de)差距，走(zou)出發展困境？而更(geng)令人(ren)值(zhi)得深思的(de)(de)(de)是(shi)(shi)，在這(zhe)(zhe)些跨國公(gong)(gong)(gong)(gong)司(si)(si)的(de)(de)(de)報(bao)告(gao)中(zhong)無一不強(qiang)調，中(zhong)國市場(chang)銷(xiao)量的(de)(de)(de)強(qiang)勢增(zeng)長(chang)(chang)(chang)是(shi)(shi)公(gong)(gong)(gong)(gong)司(si)(si)銷(xiao)售(shou)(shou)額(e)(e)增(zeng)長(chang)(chang)(chang)的(de)(de)(de)主要(yao)原(yuan)因之(zhi)(zhi)一。
上(shang)海(hai)農藥研(yan)究所(suo)顧問張一賓教授一語道出了中國(guo)農藥企業所(suo)處的江湖地(di)位。“中國(guo)農藥企業做(zuo)得再好，目前也不過是(shi)給外國(guo)公司打(da)工。”原因如此，對策何在？恐怕還需要(yao)我們深入(ru)思考。
